Publications

Interpharma members are constantly working to develop new research methods and to minimise the number of laboratory animals. However, animal experiments remain essential for researching ubiquitous diseases such as cancer, multiple sclerosis and Alzheimer’s disease, and in developing new treatments. It is therefore important that pharmaceutical companies give top priority to responsible animal use and actively implement the 10-point Animal Welfare Charter adopted by member companies of Interpharma in 2010.

The things that help the patients of today are crucial to the future of Switzerland as a pharmaceutical location. The Annual Report 2025 shows how medical advances, security of supply and economic strength are connected – and the direction that politics now needs to take.

The Innovation Report 2025 presents the latest drug approvals in Switzerland, key research trends and the tangible benefits of innovative therapies for patients and the healthcare system.